Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AZN | AMGN | GILD | BMY |
| Company | Intra-Cellular Ther | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 131.90 | 205.45 | 345.61 | 140.11 | 58.01 |
| High | 131.98 | 206.73 | 348.13 | 140.62 | 58.88 |
| Low | 131.63 | 204.27 | 342.35 | 138.47 | 57.67 |
| Latest | 131.87 | 205.45 | 345.68 | 139.50 | 58.87 |
| Change | -0.05 | +4.64 | +5.68 | +0.70 | +1.20 |
| % Change | -0.04% | +2.31% | +1.67% | +0.50% | +2.08% |
| Volume | 16,062,900 | 616,200 | 353,535 | 483,395 | 1,710,418 |
| 20-Day Average Volume | 2,474,570 | 1,816,376 | 2,580,007 | 5,874,999 | 13,080,561 |
| Previous Close | 131.92 | 200.81 | 340.00 | 138.80 | 57.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 192.70 | 353.70 | 140.26 | 59.06 |
| 20-Day Raw Stochastic | 86.25% | 98.07% | 26.66% | 42.05% | 41.13% |
| 20-Day Relative Strength | 82.75 | 61.32 | 44.27 | 49.09 | 49.47 |
| Weighted Alpha | +83.21 | +55.38 | +21.53 | +35.01 | +22.27 |
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +4.57% since 03/31/26 | -1.36% since 03/31/26 | +0.72% since 03/31/26 | -3.01% since 03/31/26 |
| Low | 131.63 on 04/01/25 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 131.98 on 04/01/25 | 206.71 on 04/08/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +6.19% since 03/06/26 | -6.08% since 03/06/26 | -2.47% since 03/06/26 | -2.43% since 03/06/26 |
| Low | 131.18 on 03/05/25 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 131.98 on 04/01/25 | 206.71 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +9.69% since 01/08/26 | +5.14% since 01/08/26 | +16.33% since 01/08/26 | +5.23% since 01/08/26 |
| Low | 80.82 on 01/07/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 131.98 on 04/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +20.78% since 10/08/25 | +17.81% since 10/08/25 | +18.71% since 10/08/25 | +32.07% since 10/08/25 |
| Low | 70.90 on 10/07/24 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 131.98 on 04/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 311,437,824 | 183,283,120 | 172,281,616 | 117,746,848 |
| Shares Outstanding, K | 106,522 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 680,850,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -74,680,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 199,220,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -16,890,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.46 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/06/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.14 | 15.68 | 17.19 | 9.65 |